Live
On Demand
Congresses
Web Events
Public
Specialty
Child Psychiatry
Dermatology
Forensic Medicine
Gynecology
Haematology
Medical Oncology
Neurology
Ophthalmology
Paediatric
Pathology
Pulmonology
Radiation Oncology
Rheumatology
Surgery
Surgical Oncology
Urology
Angiosurgery
Radiology
Allergology
Anesthesiology
Gastroenterology
General Medicine
Endocrinology
Medical Work
Cardiology
Social Medicine
Cytology
Microbiology (Medical Biopathology)
Neurosurgery
Nephrology
Orthopedics
Pathology Anatomy
Plastic Surgery
Nuclear Medicine
Physical Medicine and Rehabilitation
Thoracic Surgery
Children Surgery
Psychiatry
Otorhinolaryngology
Studio
Contact Us
ABOUT US
Support Q&A
ACCOUNT
LOG IN
REGISTER
LOG IN
REGISTER
Search ...
EN
EL
Home
Categories
18-01-2020
Go Back
Go Back
18-01-2020
37 D. Rimm - Analytic approaches to understanding PD-L1 expr...
38 N. Normanno - Liquid biopsies: facts and myths.
39 F. Hirsch - Next Generation Sequencing: is there any clin...
40 G. Bronte - Mechanisms of acquired resistance to EGFR TKI...
41 Discussion
42 L. Landi - Current treatment algorithms for EGFR-mutated...
43 B. Oyan-Uluc - Current treatment algorithms for ROS1+ pat...
44 V. Papadimitrakopoulou - Targeted therapy beyond EGFR, AL...
45 Discussion
46 E. Linardou - Lorlatinib in ALK+ NSCLC: the next step.
47 S. Agelaki - Immunotherapy in 1st line NSCLC: from trials...
48 F. Grossi - I O combination in 1st line NSCLC - practice...
49 S. Gettinger - Immunotherapy in oncogene driven mNSCLC.
50 D. Rimm - Immunotherapy biomarkers beyond PD-L1.
51 R. Pirker - The role of targeted therapies in early stage...
Next
2024
2023
2022
2021
2020
2019
2018
2017
2016
